Beyond the Gene: Why Metaphor Matters in the Story of Cancer

By Nicholas Pulliam, PhD

Metaphors are more than linguistic tools in science communication. They are framing devices—cognitive shortcuts that shape what we see, what we ignore, and what we imagine as possible. And nowhere is this more apparent than in the long and layered story of cancer.

In 1863, the German physician Rudolf Virchow examined inflamed tissue under a microscope and proposed a startling idea: that cancer might arise from “chronic irritation.” Long before the age of DNA, he intuited what modern researchers now confirm—cancer grows not only from within, but from the tissue that surrounds it.

It’s an idea that flickered, then faded, from public consciousness.

By the mid-twentieth century, cancer had been reimagined as a genetic insurgency. Mutations were the enemy, genes the map, and the cell the stage on which the drama unfolded. This narrative—elegant, urgent, and deeply persuasive—offered profound clarity, but it also narrowed our gaze.

As a science writer immersed in the history of cancer biology, I’ve come to believe that what’s been missing is not data, but language. When we focus exclusively on the genome, we risk losing an older vocabulary—one that speaks in terms of signals, scaffolds, and cellular relationships. We risk forgetting the environment that shapes the cell’s fate.

The sequencing of the human genome in the early 2000s only amplified the gene’s starring role. In the public imagination, DNA became destiny. Scientists and writers alike described oncogenes as “drivers” and tumor suppressors as “brakes,” portraying the cell as a vehicle on a molecular highway. Repair mechanisms “failed,” checkpoints “broke,” and tumors raced ahead.

These metaphors weren’t wrong. They helped translate complex biology into actionable insight. They launched targeted therapies and precision diagnostics. But metaphors also select what we see—and what we don’t. In elevating the gene, we left much of the tumor’s neighborhood in the dark.

The surrounding tissue—blood vessels, immune cells, fibroblasts, extracellular matrix—was often treated as background. Yet these components do not merely host the tumor. They nurture it. They restrain or release it. They shape its response to therapy.

Even when we described cancer cells as escaping apoptosis or resisting chemotherapy, we rarely asked what environmental cues enabled that escape. Inflammation, oxygen deprivation, and cellular cross-talk—these were the unseen hands guiding the cell’s fate.

More than a century ago, British physician Stephen Paget challenged this imbalance. After studying the distribution of metastases in breast cancer patients, he concluded that tumor cells didn’t spread randomly. They preferred certain organs. His “seed and soil” hypothesis suggested that cancer’s success depended as much on its environment as on its own properties.

But Paget’s metaphor, though prescient, was overshadowed by the clarity of mutation-centered models. His call for a more ecological view of cancer was set aside—until recently.

Today, that ecological lens is reemerging. We now know that cancer cells manipulate their surroundings—co-opting blood vessels, suppressing immune defenses, altering the very architecture of tissue. The tumor microenvironment is not inert. It is chemically alive and shaped by conflict and cooperation.

Still, we face a communication challenge. The genome gives us discrete causes. The microenvironment offers gradients, probabilities, and feedback loops. It resists reduction. It spans disciplines—mechanics, immunology, metabolism, and even microbiology. And it rarely fits on a single slide.

To describe it, we need new metaphors. Or old ones, revived and sharpened. Cancer, in this view, becomes less like a rogue nation and more like a failed state—its diplomacy collapsed, its boundaries eroded, its neighborhoods overrun by chaos and opportunism. The malignancy lies not in one actor, but in the system’s breakdown.

In exploring this subject, I’ve become increasingly drawn to the spaces between the cell: the connective tissue and scaffold. The zones of communication and tension between neighboring cells. These are not passive backdrops but chemically and mechanically alive—transmitting pressure, concentrating growth factors, shaping fate. Even the immune system, once thought to be a vigilant outsider, often emerges as both an accomplice and an adversary.

The more we learn about the tumor microenvironment, the more we must accept a difficult truth: cancer is not simply the sum of its mutations. It is the sum of its relationships—biochemical, mechanical, and spatial. That’s a harder story to tell. But it may be a truer one.

In her TED Talk “The Danger of a Single Story,” novelist Chimamanda Ngozi Adichie reminds us that narratives are not just descriptive—they are directive. They frame what we seek, and what we miss. The same applies in science. When we focus solely on the genome, we risk narrowing the kinds of therapies we imagine, and the kinds of patients we serve.

But we are not limited to a single story.

We can weave the gene with the environment, the signal with the scaffold, the mutation with the matrix. We can embrace complexity, not as confusion, but as context. And in doing so, we may begin to tell a fuller, more honest story of cancer—one that does not merely describe disease, but helps reshape how we heal.

Image Title: Components of the Tumor Microenvironment
Caption: Illustration of the tumor microenvironment, showing interactions among tumor, stromal, and immune cells within a landscape of poor perfusion, hypoxia, and metabolic stress.
Source: Wikimedia Commons
License: Creative Commons Attribution 4.0 (CC BY 4.0)
Attribution: Photo by Piñeiro Fernández, J., Luddy, K. A., Harmon, C., & O’Farrelly, C.

Nicholas Pulliam, PhD is a science writer and researcher based in Indiana. He holds a doctorate in molecular biochemistry and specializes in the intersection of cell signaling, cancer biology, and epigenetics. His forthcoming narrative nonfiction book, Beyond the Cell: A History of the Tumor Microenvironment, explores how cancer emerges not only from genetic mutations, but from the collapse of the ecological context that surrounds cells. Through storytelling that blends history, molecular biology, and clinical insight, he aims to reframe how we communicate the science of cancer—both in the lab and beyond.